Glaukos
Develops implantable glaucoma therapies and corneal cross-linking treatments.
$179.87
After-hours close−0.01 (−0.01%)
At close$179.88(−1.12%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.12 | — | — |
| Jul 2026 | −$0.21 | −$0.14 | +33.5% |
| Apr 2026 | −$0.30 | −$0.18 | +40.0% |
| Feb 2026 | −$0.22 | −$0.28 | −27.3% |
| Oct 2025 | −$0.27 | −$0.16 | +40.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.12 | — | — | $167.9M | — | — |
| Jul 29, 2026 | −$0.21 | −$0.14 | +33.5% | $150.9M | $185.6M | +23.0% |
| Apr 29, 2026 | −$0.30 | −$0.18 | +40.0% | $137.0M | $150.6M | +9.9% |
| Feb 17, 2026 | −$0.22 | −$0.28 | −27.3% | $136.4M | $143.1M | +4.9% |
| Oct 29, 2025 | −$0.27 | −$0.16 | +40.7% | $129.5M | $133.5M | +3.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 30, 2025 | ||||||
| Apr 30, 2025 | ||||||
| Feb 20, 2025 | ||||||
| Nov 4, 2024 | ||||||
| Jul 31, 2024 | ||||||
| May 1, 2024 | ||||||
| Feb 21, 2024 | ||||||
| Nov 1, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 3, 2023 | ||||||
| Feb 22, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 3, 2022 | ||||||
| May 4, 2022 | ||||||
| Feb 22, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 5, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 27, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 8, 2019 | ||||||
| Feb 27, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 2, 2018 | ||||||
| May 9, 2018 | ||||||
| Feb 28, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 2, 2017 | ||||||
| May 3, 2017 | ||||||
| Mar 1, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Aug 1, 2016 | ||||||
| May 3, 2016 | ||||||
| Mar 1, 2016 | ||||||
| Nov 10, 2015 | ||||||
| Aug 12, 2015 | ||||||